Here, we analysed the effects of DNMT3A silencing in ERMS cells and the ability of the de novo DNMT3A- and DNMT3B-specific depletion to potentiate the efficacy of radiation treatment, since IR alone did not decrease DNMT3A and DNMT3B expression levels. The gene discussed is DNMT3B; the disease is embryonal rhabdomyosarcoma.